Table 1

Treatment data on patients treated with irinotecan, thalidomide, and doxycycline
Patient
 Age
 Histology
 Number of Cycles
 TTPa
 OSa
1
 61
 anaplastic oligodendroglioma
 4
 6 months
 17+ months
2
 67
 glioblastoma multiforme
 3
 4 months
 10 months
3
 54
 anaplastic astrocytoma
 1
 N/A
 5 month
4
 34
 anaplastic oligodendroglioma
 2
 N/A
 8 months

aTTP = time to tumor progression; OS = overall survival

Wong et al. Cerebrospinal Fluid Research 2008 5:1   doi:10.1186/1743-8454-5-1